An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ.
Ye K, Li F, Wang R, Cen T, Liu S, Zhao Z, Li R, Xu L, Zhang G, Xu Z, Deng L, Li L, Wang W, Stepanov A, Wan Y, Guo Y, Li Y, Wang Y, Tian Y, Gabibov AG, Yan Y, Zhang H.
Ye K, et al.
Mol Ther. 2022 Dec 7;30(12):3658-3676. doi: 10.1016/j.ymthe.2022.06.010. Epub 2022 Jun 17.
Mol Ther. 2022.
PMID: 35715953
Free PMC article.